Back to top of page

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

List of required information for application:

1. Project title

2. Project summary/abstract

3. Project objectives

4. Target disease/condition being addressed

5. Target identification and validation strategy

6. Approach/methods for preliminary product/lead series identification

7. Expected outcomes and impact of the project

8. Project timeline/duration

9. Budget breakdown and justification

10. Principal Investigator (PI) information (name, affiliation, contact details)

11. Collaborators or team members involved in the project

12. Relevant prior research or preliminary data

13. Any potential conflicts of interest

14. Potential future funding sources or plans for preclinical optimization and development

15. Any other supporting documents or supplementary information required for the application process.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows